Enzo Biochem Inc
(ENZB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 10-2017 | 07-2017 | 04-2017 | 01-2017 | 10-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -640 | -2,504 | -2,598 | -2,527 | -1,474 |
| Depreciation Amortization | 749 | 3,598 | 2,692 | 1,842 | 927 |
| Accounts receivable | 713 | -469 | -3,192 | -2,170 | -150 |
| Accounts payable and accrued liabilities | -819 | 515 | -459 | 238 | -522 |
| Other Working Capital | 2,083 | -2,378 | -5,376 | -4,307 | -955 |
| Other Operating Activity | 509 | 1,033 | 7,039 | 4,092 | 1,841 |
| Operating Cash Flow | $2,595 | $-205 | $-1,894 | $-2,832 | $-333 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -461 | -1,753 | -1,424 | -689 | -514 |
| Other Investing Activity | 0 | 4 | 6 | 2 | 0 |
| Investing Cash Flow | $-461 | $-1,749 | $-1,418 | $-687 | $-514 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 40,694 | 40,694 | 24,297 |
| Debt Issued | N/A | 40,694 | N/A | N/A | N/A |
| Debt Repayment | -101 | -42,816 | -428 | -323 | -146 |
| Common Stock Issued | 658 | 453 | 159 | 71 | 6 |
| Other Financing Activity | 0 | 0 | -42,250 | -42,251 | -23,854 |
| Financing Cash Flow | $557 | $-1,669 | $-1,825 | $-1,809 | $303 |
| Exchange Rate Effect | -9 | 13 | -13 | -22 | -19 |
| Beginning Cash Position | 64,167 | 67,777 | 67,777 | 67,777 | 67,777 |
| End Cash Position | 66,849 | 64,167 | 62,627 | 67,427 | 67,214 |
| Net Cash Flow | $2,682 | $-3,610 | $-5,150 | $-5,350 | $-563 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,595 | -205 | -1,894 | -2,832 | -333 |
| Capital Expenditure | -461 | -1,753 | -1,424 | -689 | -514 |
| Free Cash Flow | 2,134 | -1,958 | -3,318 | -3,521 | -847 |